Owner of Steven Bartlett-founded Social Chain eyes swoop for AIM-listed Mission May 12, 2024 London-based Brave Bison is currently in discussions with Mission's board and major shareholders to garner support for their proposal.
Winding-up petition puts Chamberlin’s future in doubt as shares suspended May 7, 2024 The future of specialist castings and machining group Chamberlin has been placed into serious doubt after it was issued with a winding-up petition and its shares were suspended from trading.
AIM hit by sharp liquidity drop in further blow to London market May 6, 2024 Companies listed on the UK's AIM have seen the average value of their shares trading fall over 15 per cent in the last year.
London tech company’s profits treble as stock soars over 130 per cent May 1, 2024 Maintel, which is a London tech company that provides cloud services for businesses, said revenue for the year, ending December 2023, was £101.3m, up 11.3 per cent year-on-year.
AIM delistings jump 62 per cent as London’s small cap market suffers April 22, 2024 The number of companies delisting from London's Alternative Investment Market (AIM) has soared past pandemic-era highs.
Chapel Down: Record harvest helps UK’s biggest winemaker fizz to the top April 16, 2024 Chapel Down has reported record company sales for the year ended 31st December following a strong harvest.
Is the London Stock Exchange’s AIM in terminal decline? April 10, 2024 The number of firms listed on London's AIM has cratered 30 per cent from 1,104 to just 742 in the last 10 years. Why?
‘Lack of appetite’ in London drives another high-tech firm to Nasdaq April 10, 2024 In a statement to markets this morning, London-HQd e-therapeutics said it has "an intention to cancel its admission to AIM and subsequently explore the option of listing on NASDAQ in due course."
London loses another listed company as pharma riser goes private April 2, 2024 Shareholders will vote on the decision on 19 April, requiring 75 per cent to vote in favour of the move, it confirmed in a statement to markets this morning.
Another listed company plans to quit London’s AIM market – this is why March 27, 2024 Drug company C4X Discovery has announced plans to quit the London Stock Exchange's AIM.